SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-18-028082
Filing Date
2018-11-07
Accepted
2018-11-07 16:40:48
Documents
74
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q ptla-10q_20180930.htm 10-Q 2654076
2 EX-10.44 ptla-ex1044_21.htm EX-10.44 63440
3 EX-31.1 ptla-ex311_11.htm EX-31.1 9933
4 EX-31.2 ptla-ex312_7.htm EX-31.2 9954
5 EX-32.1 ptla-ex321_10.htm EX-32.1 9412
6 GRAPHIC gtfdlbvgfqcq000001.jpg GRAPHIC 3430
  Complete submission text file 0001564590-18-028082.txt   11166218

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT ptla-20180930.xml EX-101.INS 2945258
8 XBRL TAXONOMY EXTENSION SCHEMA ptla-20180930.xsd EX-101.SCH 70403
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ptla-20180930_cal.xml EX-101.CAL 57463
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ptla-20180930_def.xml EX-101.DEF 273888
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE ptla-20180930_lab.xml EX-101.LAB 488752
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ptla-20180930_pre.xml EX-101.PRE 430039
Mailing Address 270 EAST GRAND AVENUE, SUITE 22 SOUTH SAN FRANCISCO CA 94080
Business Address 270 EAST GRAND AVENUE, SUITE 22 SOUTH SAN FRANCISCO CA 94080 650-244-6864
PORTOLA PHARMACEUTICALS INC (Filer) CIK: 0001269021 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35935 | Film No.: 181166911
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1